Markets:

Overview

News

Currencies

International

Treasuries

ImmunityBio, Inc. - Common Stock (NQ:IBRX)

6.390 -0.060 (-0.93%)

Streaming Delayed Price Updated: 2:14 PM EST, Jan 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ImmunityBio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Booz Allen Posts Upbeat Q3 Earnings, Joins Deckers Outdoor, Saia, Boyd Gaming And Other Big Stocks Moving Higher On Friday ↗

October 25, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 25, 2024

Via Benzinga

Top 2 Health Care Stocks That May Fall Off A Cliff This Month ↗

October 25, 2024

Via Benzinga

Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗

October 25, 2024

Via Benzinga

How Is The Market Feeling About ImmunityBio? ↗

May 17, 2024

Via Benzinga

First Patients Dosed in Phase 1 Clinical Study of ImmunityBio’s CAR-NK Cell Therapy for the Treatment of Relapsed B-Cell Non-Hodgkin Lymphoma

October 24, 2024

From ImmunityBio, Inc.

Via Business Wire

800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio ↗

October 23, 2024

EF Hutton rates ImmunityBio (IBRX) as a Buy with a $30 target. Anktiva shows promise in cancer treatment, boosting response rates and survival outcomes.

Via Benzinga

Texas Instruments Posts Strong Q3 Results, Joins Valmont Industries, Lithia Motors, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday ↗

October 23, 2024

Via Benzinga

ImmunityBio to Participate in the Jefferies London Healthcare Conference

October 21, 2024

From ImmunityBio, Inc.

Via Business Wire

Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket ↗

September 12, 2024

Via Benzinga

Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday ↗

September 09, 2024

Via Benzinga

ImmunityBio Presents Positive Long-Term Overall Survival Data in Non-Small Cell Lung Cancer Patients and Announces Registrational Intent Phase 3 Trials with ANKTIVA® and Checkpoint Immunotherapy at World Conference on Lung Cancer

September 09, 2024

From ImmunityBio, Inc.

Via Business Wire

Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 19, 2024

Via Benzinga

Top 3 Health Care Stocks That Are Set To Fly This Quarter ↗

August 16, 2024

Via Benzinga

9 Health Care Stocks Whale Activity In Today's Session ↗

August 13, 2024

Via Benzinga

IBRX Stock Earnings: ImmunityBio Misses EPS, Misses Revenue for Q2 2024 ↗

August 12, 2024

IBRX stock results show that ImmunityBio missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

ImmunityBio’s ANKTIVA® Now Covered By More Than a Dozen Insurance Plans Representing Over 100 Million Lives Within Months of FDA Approval

August 12, 2024

From ImmunityBio, Inc.

Via Business Wire

ImmunityBio Announces Study of ANKTIVA® in Combination with the AdHER2DC Cancer Vaccine as a Potential Therapy to Control Endometrial Cancer

August 06, 2024

From ImmunityBio, Inc.

Via Business Wire

IMMUNITYBIO INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ImmunityBio, Inc. - IBRX

July 26, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

7 Biotech Stocks to Keep on Your Clinical Radar ↗

July 23, 2024

Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs.

Via InvestorPlace

3 Top Cancer Treatment Stocks to Buy Now ↗

July 17, 2024

These cancer treatment stocks are well-positioned to benefit tremendously from strong demand for their cancer treatments in the longer term.

Via InvestorPlace

China's Bilibili And Ollie's Bargain Outlet Were Among 10 Mid Cap Stocks With Biggest Gains In The Last Week (June 16-June 22, 2024): Are They In Your Portfolio? ↗

June 23, 2024

Top performing mid-cap stocks last week: BILI (+23%), IBRX (+22%), SSL (+20%), OLLI (+15%), ITCI (+13%), AMKR (+12%), IRTC (+11%), RKLB (+11%), BFH (+10%), BRFS (+10%).

Via Benzinga

Why ImmunityBio Stock Is Trading Higher Thursday ↗

June 20, 2024

The company announced insurance coverage of ANKTIVA, a immunotherapy used to treat non-muscle invasive bladder cancer that was unresponsive to other specific treatments.

Via Benzinga

KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday ↗

June 20, 2024

Via Benzinga

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 20, 2024

Via Benzinga

ImmunityBio Announces Insurance Coverage of ANKTIVA® Across Multiple States with First Commercial Doses Administered Just Weeks After FDA Approval—Opening New Era for Immunotherapy Beyond Checkpoint Inhibitors

June 20, 2024

From ImmunityBio, Inc.

Via Business Wire

3 Short-Squeeze Stocks Outwitting the Pessimistic Predictions ↗

June 20, 2024

Don't be discouraged by the bears. Here are my three picks of short-squeeze stocks to buy for investors everywhere.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 11, 2024

Via Benzinga

ImmunityBio Announces 2024 Annual Meeting of Stockholders with Company Update

June 07, 2024

From ImmunityBio, Inc.

Via Business Wire

These 3 Interesting Stocks Are Seeing Heavy Short Interest In June 2024 ↗

June 04, 2024

Economic slowdown meets short-selling speculations. Candidates for incoming market volatility are here.

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.